logo

COURSE STRUCTURE

Supported by Pfizer

RECENT ANNOUNCEMENTS

No announcements have been made for this course

General

Skill level: All levels
Estimated time to complete activity: 30 minutes
Release date: November 27, 2019
Expiration date: November 27, 2022

Languages

English

Accreditations

Continuing Nursing Education(CNE), Continuing Medical Education(CME)

Description

Itch is the quintessential symptom of AD. Choosing the best systemic therapy for AD that will also synergize with the patient’s itch is an opportunity often missed. Through case-based learning, the pathways of itch in AD are reviewed and potential therapies are offered.

Target Audience

This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with atopic dermatitis.

Educational Objectives

  • Examine the pathways of itch in moderate to severe AD
  • Formulate an approach for the treatment of itch

Disclosure of Conflicts of Interest

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, LearnHealth, and/or Pfizer, Sanofi Genzyme and Regeneron Pharmaceuticals, and Incyte. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Faculty Reported Financial Relationship
Gil Yosipovitch, MD

Advisory Board Member: Trevi, Menlo, Sienna, Pfizer, Sanofi, Regeneron, Novartis,Galderma, Kinksa, Eli Lilly, Cerave, Bayer, Abbvie, Bellus

PI: Pfizer, Leo, Sanofi, Kiniksa, Vanda

Funded: Pfizer, Sun Pharma, Leo, Menlo

AuthorLiving with Itch

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager Reported Financial Relationship
Venita Sivamani, Planner LearnHealth founder and shareholder
Planners at Medical Education Resources No financial relationships to disclose

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and LearnHealth. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This CE activity provides 0.5 contact hours of continuing nursing education.

Provider approved by the California Board of Registered Nursing, Provider Number 12299 for 0.5 contact hours.

Method of Participation

There are no fees for participating in and receiving credit for this activity. During the period November 27, 2019 through November 27, 2022, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.

Media

Internet

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, LearnHealth, and Pfizer. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

CONTACT INFORMATION

This activity is jointly provided by Medical Education Resources and LearnHealth Inc.

For questions regarding accreditation, please contact MER at 800-421-3756. For all other questions, please contact info@learnskin.com.

This activity is subject to MER's Privacy Policy and LearnSkin's Terms of Use.

 
 
  Share